Vivos Inc (RDGL)
RDGL is quoted over the counter, not listed on an exchange. Vivos Inc files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | RDGL, quoted over the counter |
| SEC CIK | 0001449349 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Business address | Richland, WA |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Based on the Company's financial history since inception, the Company's independent registered public accounting firm has expressed substantial doubt as to the Company's ability to continue as a going concern." | 10-Q 2026-11-12 |
| Cash and burn | $1.8M cash; operating cash flow -$576K a quarter. | Report 2026-09-30 |
| Shares outstanding | 494,738,110 (2026-11-12); 454,664,957 a year earlier; 370,994,857 three years earlier. | Cover page 2026-11-12 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Fruci & Associates II, PLLC, Spokane, Washington, United States | PCAOB Form AP 2026-04-02 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $67K, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $29K | -$732K | -$593K | $1.8M | No debt tags | $126K | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $36K | -$830K | -$740K | $2.3M | No debt tags | $99K | 10-Q 2026-08-12 |
| Q1 2026 2026-03-31 | $36K | -$1.2M | -$430K | $2.5M | No debt tags | $78K | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $25K | -$1.1M | -$540K | $1.6M | No debt tags | $68K | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $2K | -$507K | -$458K | $2.2M | No debt tags | $49K | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $15K | -$646K | -$605K | $2.7M | No debt tags | $52K | 10-Q 2026-08-12 |
| Q1 2025 2025-03-31 | $27K | -$835K | -$455K | $3.3M | No debt tags | $50K | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $5K | -$1.0M | -$471K | $2.2M | No debt tags | $28K | 10-K 2026-03-31 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 1-A/A | 2026-03-04 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-11-05 |
| Latest proxy | DEF 14A | 2026-11-09 |
Source: SEC EDGAR submissions feed, 499 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier